GLUD1 and pancreatic neoplasm: Additionally, PCSCs carrying shControl, shGLUD1, and shGOT1#2 were subjected to 2 weeks of culture with fractional IR treatment, and suppression of GOT1—but not GLUD1—significantly increased radiosensitivity in PCSCs from both pancreatic cancer cell lines (Fig. 5C).